Geary Richard S's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Sep 3, 2024
- Accession no.
- 0000874015-24-000191
- Filed
- Sep 3, 2024
- Trade date
- Aug 28-29, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $32.2K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Geary Richard SCIK 0001442730 | Officer (EVP, Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | Common Stock | SSaleDisposed | −320 | $49.16 | −$15,731.2 | 85,154 | Direct | |
| Aug 29, 2024 | Common Stock | SSaleDisposed | −331 | $49.63 | −$16,427.53 | 84,823 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.